Pool Corporation vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 83)

Pool Corporation

LeaderConsumer Retail

Enterprise

Covington LA pool supplies wholesale distributor (NASDAQ: POOL) at $5.3B 2024 revenue (-4%); 440+ service centers, 6M+ US pool installed base maintenance, 200,000+ SKUs for pool builders competing with regional distributors.

AI VisibilityBeta
Overall Score
A83
Category Rank
#230 of 290
AI Consensus
78%
Trend
stable
Per Platform
ChatGPT
76
Perplexity
85
Gemini
84

About

Pool Corporation is a Covington, Louisiana-based wholesale distributor of swimming pool supplies, equipment, and related outdoor living products — publicly traded on NASDAQ (NASDAQ: POOL) as an S&P 500 Consumer Discretionary component — operating as the world's largest wholesale distributor of swimming pool and related outdoor products through a network of 440+ service centers across the United States, Canada, Australia, and Europe, serving approximately 125,000 customers including pool builders, retailers, and service companies through approximately 6,400 employees. In fiscal year 2024, Pool Corporation reported annual net sales of $5.3 billion, a 4% decrease from 2023, with diluted EPS of $11.30, operating cash flow of $659.2 million, and an operating margin of 11.6% — reflecting softer discretionary spending in new pool construction while maintenance chemicals, equipment replacement, and repair parts sustained non-discretionary demand. Founded in 1993 through the consolidation of regional pool supply distributors, Pool Corporation (operating under the SCP Pool and Horizon Distributors brand names) built its distribution moat through a hub-and-spoke service center network that delivers products next-morning to pool builders and service companies in virtually every US market. CEO Peter Arvan has led the company's strategy of expanding into outdoor living products (patio furniture, landscaping equipment, irrigation) beyond the core pool supplies business.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

83
Overall Score
90
#230
Category Rank
#9
78
AI Consensus
60
stable
Trend
stable
76
ChatGPT
99
85
Perplexity
99
84
Gemini
83
80
Claude
96
83
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.